Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100ST0Z
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥99.3bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥19.3bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥19.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥19.8bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥210.7bnat 2023-12-31Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥195.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥37.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥173.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥65.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥450.772023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.462023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio82.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥9.4bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.1bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥19.3bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Operating incomePrior1YTDDuration16077000000JPY
Operating incomeCurrentYTDDuration19286000000JPY
Interest income noiPrior1YTDDuration51000000JPY
Interest income noiCurrentYTDDuration70000000JPY
Dividends income noiPrior1YTDDuration145000000JPY
Dividends income noiCurrentYTDDuration168000000JPY
Foreign exchange gains noiPrior1YTDDuration306000000JPY
Foreign exchange gains noiCurrentYTDDuration－JPY
Gain on investments in partnership noiPrior1YTDDuration17000000JPY
Gain on investments in partnership noiCurrentYTDDuration1000000JPY
Other noiPrior1YTDDuration201000000JPY
Other noiCurrentYTDDuration147000000JPY
Non operating incomePrior1YTDDuration721000000JPY
Non operating incomeCurrentYTDDuration387000000JPY
Interest expenses noePrior1YTDDuration26000000JPY
Interest expenses noeCurrentYTDDuration25000000JPY
Foreign exchange losses noePrior1YTDDuration－JPY
Foreign exchange losses noeCurrentYTDDuration27000000JPY
Other noePrior1YTDDuration6000000JPY
Other noeCurrentYTDDuration18000000JPY
Non operating expensesPrior1YTDDuration33000000JPY
Non operating expensesCurrentYTDDuration70000000JPY
Ordinary incomePrior1YTDDuration16766000000JPY
Ordinary incomeCurrentYTDDuration19603000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration9000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration5000000JPY
Surrender value of insurance eiPrior1YTDDuration167000000JPY
Surrender value of insurance eiCurrentYTDDuration197000000JPY
Gain on extinguishment of tie in shares eiPrior1YTDDuration67000000JPY
Gain on extinguishment of tie in shares eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration244000000JPY
Extraordinary incomeCurrentYTDDuration202000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration14000000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration5000000JPY
Impairment loss elPrior1YTDDuration59000000JPY
Impairment loss elCurrentYTDDuration5000000JPY
Loss on valuation of investment securities elPrior1YTDDuration53000000JPY
Loss on valuation of investment securities elCurrentYTDDuration26000000JPY
Office transfer expenses elPrior1YTDDuration4000000JPY
Office transfer expenses elCurrentYTDDuration8000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration133000000JPY
Extraordinary lossCurrentYTDDuration46000000JPY
Income before income taxesPrior1YTDDuration16877000000JPY
Income before income taxesCurrentYTDDuration19759000000JPY
Income taxes currentPrior1YTDDuration5159000000JPY
Income taxes currentCurrentYTDDuration5671000000JPY
Income taxes deferredPrior1YTDDuration111000000JPY
Income taxes deferredCurrentYTDDuration451000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass